25 XP   0   0   10

OpGen Inc
Buy, Hold or Sell?

Let's analyse Opgen together

PenkeI guess you are interested in OpGen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of OpGen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about OpGen Inc

I send you an email if I find something interesting about OpGen Inc.

Quick analysis of Opgen (30 sec.)










What can you expect buying and holding a share of Opgen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$0.76
Expected worth in 1 year
$-12.68
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-13.44
Return On Investment
-2,526.0%

For what price can you sell your share?

Current Price per Share
$0.53
Expected price per share
$0.451 - $2.08
How sure are you?
50%

1. Valuation of Opgen (5 min.)




Live pricePrice per Share (EOD)

$0.53

Intrinsic Value Per Share

$-28.36 - $-21.25

Total Value Per Share

$-27.60 - $-20.50

2. Growth of Opgen (5 min.)




Is Opgen growing?

Current yearPrevious yearGrowGrow %
How rich?$7.5m$41.2m-$33.6m-444.1%

How much money is Opgen making?

Current yearPrevious yearGrowGrow %
Making money-$36.7m-$34.8m-$1.9m-5.3%
Net Profit Margin-1,409.2%-808.3%--

How much money comes from the company's main activities?

3. Financial Health of Opgen (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Opgen? (5 min.)

Welcome investor! Opgen's management wants to use your money to grow the business. In return you get a share of Opgen.

What can you expect buying and holding a share of Opgen?

First you should know what it really means to hold a share of Opgen. And how you can make/lose money.

Speculation

The Price per Share of Opgen is $0.532. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Opgen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Opgen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.76. Based on the TTM, the Book Value Change Per Share is $-3.36 per quarter. Based on the YOY, the Book Value Change Per Share is $2.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Opgen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-3.72-699.9%-3.72-699.9%-3.48-653.4%-2.48-466.0%-1.93-362.4%
Usd Book Value Change Per Share-3.36-631.5%-3.36-631.5%2.00375.9%0.1223.2%0.0814.2%
Usd Dividend Per Share0.000.0%0.000.0%0.72134.5%0.1426.9%0.0713.5%
Usd Total Gains Per Share-3.36-631.5%-3.36-631.5%2.72510.4%0.2750.1%0.1527.7%
Usd Price Per Share0.14-0.14-1.00-1.12-0.88-
Price to Earnings Ratio-0.04--0.04--0.29--0.60--0.48-
Price-to-Total Gains Ratio-0.04--0.04-0.37-3.97-2.17-
Price to Book Ratio0.19-0.19-0.24-1.59-1.55-
Price-to-Total Gains Ratio-0.04--0.04-0.37-3.97-2.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.532
Number of shares1879
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.14
Usd Book Value Change Per Share-3.360.12
Usd Total Gains Per Share-3.360.27
Gains per Quarter (1879 shares)-6,312.65500.71
Gains per Year (1879 shares)-25,250.592,002.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-25251-2526110769271993
20-50501-50512215218543996
30-75752-75763322827815999
40-101002-101014430337088002
50-126253-1262655379463510005
60-151504-1515166455556212008
70-176754-1767677531648914011
80-202005-2020188607741616014
90-227255-2272699683834318017
100-252506-25252010759927020020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%5.05.00.050.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.09.010.0%1.00.09.010.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.05.00.050.0%5.05.00.050.0%

Fundamentals of Opgen

About OpGen Inc

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

Fundamental data was last updated by Penke on 2024-04-11 16:59:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of OpGen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Opgen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • A Net Profit Margin of -1,409.2% means that $-14.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of OpGen Inc:

  • The MRQ is -1,409.2%. The company is making a huge loss. -2
  • The TTM is -1,409.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,409.2%TTM-1,409.2%0.0%
TTM-1,409.2%YOY-808.3%-600.9%
TTM-1,409.2%5Y-720.6%-688.6%
5Y-720.6%10Y-566.6%-154.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,409.2%-12.4%-1,396.8%
TTM-1,409.2%-20.4%-1,388.8%
YOY-808.3%-14.4%-793.9%
5Y-720.6%-21.3%-699.3%
10Y-566.6%-25.0%-541.6%
1.1.2. Return on Assets

Shows how efficient Opgen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • -142.2% Return on Assets means that Opgen generated $-1.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of OpGen Inc:

  • The MRQ is -142.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -142.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-142.2%TTM-142.2%0.0%
TTM-142.2%YOY-48.6%-93.7%
TTM-142.2%5Y-99.4%-42.8%
5Y-99.4%10Y-160.3%+60.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-142.2%-4.1%-138.1%
TTM-142.2%-4.7%-137.5%
YOY-48.6%-4.6%-44.0%
5Y-99.4%-4.0%-95.4%
10Y-160.3%-5.2%-155.1%
1.1.3. Return on Equity

Shows how efficient Opgen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • -485.0% Return on Equity means Opgen generated $-4.85 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of OpGen Inc:

  • The MRQ is -485.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -485.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-485.0%TTM-485.0%0.0%
TTM-485.0%YOY-84.4%-400.5%
TTM-485.0%5Y-269.6%-215.4%
5Y-269.6%10Y-328.3%+58.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-485.0%-4.2%-480.8%
TTM-485.0%-5.8%-479.2%
YOY-84.4%-5.5%-78.9%
5Y-269.6%-6.3%-263.3%
10Y-328.3%-7.1%-321.2%

1.2. Operating Efficiency of OpGen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Opgen is operating .

  • Measures how much profit Opgen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • An Operating Margin of -1,325.8% means the company generated $-13.26  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of OpGen Inc:

  • The MRQ is -1,325.8%. The company is operating very inefficient. -2
  • The TTM is -1,325.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,325.8%TTM-1,325.8%0.0%
TTM-1,325.8%YOY-536.5%-789.3%
TTM-1,325.8%5Y-626.6%-699.1%
5Y-626.6%10Y-506.3%-120.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,325.8%-24.3%-1,301.5%
TTM-1,325.8%-16.4%-1,309.4%
YOY-536.5%-14.0%-522.5%
5Y-626.6%-20.4%-606.2%
10Y-506.3%-24.8%-481.5%
1.2.2. Operating Ratio

Measures how efficient Opgen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 9.52 means that the operating costs are $9.52 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of OpGen Inc:

  • The MRQ is 9.522. The company is inefficient in keeping operating costs low. -1
  • The TTM is 9.522. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.522TTM9.5220.000
TTM9.522YOY6.365+3.157
TTM9.5225Y6.319+3.202
5Y6.31910Y5.591+0.729
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.5221.456+8.066
TTM9.5221.439+8.083
YOY6.3651.431+4.934
5Y6.3191.436+4.883
10Y5.5911.374+4.217

1.3. Liquidity of OpGen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Opgen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.01 means the company has $1.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of OpGen Inc:

  • The MRQ is 1.006. The company is just able to pay all its short-term debts.
  • The TTM is 1.006. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.006TTM1.0060.000
TTM1.006YOY1.995-0.989
TTM1.0065Y1.592-0.586
5Y1.59210Y1.279+0.313
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0062.693-1.687
TTM1.0062.697-1.691
YOY1.9953.504-1.509
5Y1.5923.617-2.025
10Y1.2793.499-2.220
1.3.2. Quick Ratio

Measures if Opgen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • A Quick Ratio of 0.75 means the company can pay off $0.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of OpGen Inc:

  • The MRQ is 0.751. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.751. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.751TTM0.7510.000
TTM0.751YOY1.870-1.119
TTM0.7515Y1.365-0.614
5Y1.36510Y1.080+0.285
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7511.516-0.765
TTM0.7511.658-0.907
YOY1.8702.142-0.272
5Y1.3652.307-0.942
10Y1.0802.370-1.290

1.4. Solvency of OpGen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Opgen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Opgen to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.71 means that Opgen assets are financed with 70.7% credit (debt) and the remaining percentage (100% - 70.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of OpGen Inc:

  • The MRQ is 0.707. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.707. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.707TTM0.7070.000
TTM0.707YOY0.425+0.282
TTM0.7075Y0.585+0.122
5Y0.58510Y1.043-0.459
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7070.402+0.305
TTM0.7070.389+0.318
YOY0.4250.335+0.090
5Y0.5850.442+0.143
10Y1.0430.461+0.582
1.4.2. Debt to Equity Ratio

Measures if Opgen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Opgen to the Medical Devices industry mean.
  • A Debt to Equity ratio of 241.0% means that company has $2.41 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of OpGen Inc:

  • The MRQ is 2.410. The company is just not able to pay all its debts with equity.
  • The TTM is 2.410. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.410TTM2.4100.000
TTM2.410YOY0.739+1.671
TTM2.4105Y1.526+0.884
5Y1.52610Y1.403+0.123
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4100.559+1.851
TTM2.4100.560+1.850
YOY0.7390.479+0.260
5Y1.5260.614+0.912
10Y1.4030.674+0.729

2. Market Valuation of OpGen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Opgen generates.

  • Above 15 is considered overpriced but always compare Opgen to the Medical Devices industry mean.
  • A PE ratio of -0.04 means the investor is paying $-0.04 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of OpGen Inc:

  • The EOD is -0.143. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.038. Based on the earnings, the company is expensive. -2
  • The TTM is -0.038. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.143MRQ-0.038-0.105
MRQ-0.038TTM-0.0380.000
TTM-0.038YOY-0.288+0.250
TTM-0.0385Y-0.598+0.560
5Y-0.59810Y-0.478-0.119
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.143-1.021+0.878
MRQ-0.038-1.704+1.666
TTM-0.038-2.081+2.043
YOY-0.288-2.980+2.692
5Y-0.598-2.379+1.781
10Y-0.478-1.726+1.248
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of OpGen Inc:

  • The EOD is -0.253. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.067. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.067. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.253MRQ-0.067-0.186
MRQ-0.067TTM-0.0670.000
TTM-0.067YOY-0.427+0.360
TTM-0.0675Y-0.701+0.633
5Y-0.70110Y-0.561-0.140
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.253-0.981+0.728
MRQ-0.067-1.578+1.511
TTM-0.067-2.973+2.906
YOY-0.427-6.179+5.752
5Y-0.701-4.928+4.227
10Y-0.561-5.060+4.499
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Opgen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.19 means the investor is paying $0.19 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of OpGen Inc:

  • The EOD is 0.703. Based on the equity, the company is cheap. +2
  • The MRQ is 0.186. Based on the equity, the company is cheap. +2
  • The TTM is 0.186. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.703MRQ0.186+0.517
MRQ0.186TTM0.1860.000
TTM0.186YOY0.243-0.057
TTM0.1865Y1.593-1.406
5Y1.59310Y1.547+0.045
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.7031.930-1.227
MRQ0.1862.372-2.186
TTM0.1862.444-2.258
YOY0.2433.205-2.962
5Y1.5933.893-2.300
10Y1.5474.245-2.698
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of OpGen Inc.

3.1. Institutions holding OpGen Inc

Institutions are holding 2.684% of the shares of OpGen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Renaissance Technologies Corp0.6591066000660000
2023-12-31Vanguard Group Inc0.5320532751657445.1595
2023-12-31Virtu Financial LLC0.40330.001440384403840
2023-12-31Geode Capital Management, LLC0.3671036755-9677-20.8412
2023-12-31BlackRock Inc0.160201604000
2023-12-31TWO SIGMA SECURITIES, LLC0.12090.000112102121020
2023-12-31Tower Research Capital LLC0.072307242-799-9.9366
2023-12-31Wells Fargo & Co0.00250251195348.2143
2023-12-31Qube Research & Technologies0.00202002000
2023-12-31Royal Bank of Canada0.000505000
2023-12-31Goss Wealth Management LLC0.000505000
2023-12-31Focused Wealth Strategies, INC.0.000202500
2023-12-31UBS Group AG0.000101300
2023-12-31Susquehanna International Group, LLP000-10193-100
2023-12-31Baader Bank INC000-171110-100
2023-09-30Valley National Advisers Inc000-25-100
2023-12-31Arete Wealth Advisors, LLC000-15000-100
2023-09-30Armistice Capital, LLC000-626175-100
2023-12-31BP WEALTH MANAGEMENT, LLC000-18219-100
2023-09-30Bank of America Corp000-1-100
Total 2.32070.0015232387-715744-308.0%

3.2. Funds holding OpGen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.443405327500
2024-02-29Fidelity Extended Market Index0.235902834200
2024-02-29Fidelity Total Market Index0.02520303200
2024-02-29Fidelity Series Total Market Index0.02270273200
2024-03-31State St US Extended Mkt Indx NL Cl C0.01620.0001194400
2023-12-31SSgA U.S. Extended Market Index Class I0.01620194400
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.01540185500
2023-12-31NT Ext Equity Mkt Idx Fd - L0.01290154800
2023-12-31Northern Trust Extended Eq Market Idx0.01290154800
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.01240149030.2017
2024-02-29Fidelity Nasdaq Composite Index0.01090130500
2024-02-29Spartan Total Market Index Pool E0.0074089000
2023-12-31SSgA U.S. Total Market Index Strategy0.00470561-13-2.2648
2024-02-29Spartan Extended Market Index Pool E0.0038045400
2024-02-29State St US Ttl Mkt Indx SL Cl I0.0022026400
2023-12-31BNYM Mellon SL Market Completion UC10.00160197-3-1.5
2023-09-30BlackRock Extended Mkt Composite0.000809900
2023-12-31NT US Market Cap Idx Fd - L0.000607500
2023-12-31Northern Trust Wilshire 50000.000607500
2023-12-31BNYM Mellon NSL Mkt Completion Fund Inst0.000606800
Total 0.84640.0001101698-130.0%

3.3. Insider Transactions

Insiders are holding 0.417% of the shares of OpGen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-01-26Johannes BacherBUY250000.85
2021-11-18Oliver SchachtBUY100001.5
2021-09-15Johannes BacherBUY50003.07

4. Summary

4.1. Key Performance Indicators

The key performance indicators of OpGen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.360-3.3600%2.000-268%0.123-2824%0.076-4541%
Book Value Per Share--0.7570.7570%4.116-82%1.550-51%0.796-5%
Current Ratio--1.0061.0060%1.995-50%1.592-37%1.279-21%
Debt To Asset Ratio--0.7070.7070%0.425+66%0.585+21%1.043-32%
Debt To Equity Ratio--2.4102.4100%0.739+226%1.526+58%1.403+72%
Dividend Per Share----0%0.716-100%0.143-100%0.072-100%
Eps---3.723-3.7230%-3.476-7%-2.479-33%-1.928-48%
Free Cash Flow Per Share---2.101-2.1010%-2.343+12%-1.813-14%-1.500-29%
Free Cash Flow To Equity Per Share---2.774-2.7740%2.396-216%0.200-1485%0.034-8216%
Gross Profit Margin--1.1181.1180%1.107+1%1.118+0%1.197-7%
Intrinsic Value_10Y_max---21.253--------
Intrinsic Value_10Y_min---28.361--------
Intrinsic Value_1Y_max---1.886--------
Intrinsic Value_1Y_min---2.435--------
Intrinsic Value_3Y_max---5.852--------
Intrinsic Value_3Y_min---7.712--------
Intrinsic Value_5Y_max---10.042--------
Intrinsic Value_5Y_min---13.382--------
Market Cap5327182.000+73%1411903.5001411903.5000%10013500.000-86%11237149.700-87%8859744.530-84%
Net Profit Margin---14.092-14.0920%-8.083-43%-7.206-49%-5.666-60%
Operating Margin---13.258-13.2580%-5.365-60%-6.266-53%-5.063-62%
Operating Ratio--9.5229.5220%6.365+50%6.319+51%5.591+70%
Pb Ratio0.703+73%0.1860.1860%0.243-23%1.593-88%1.547-88%
Pe Ratio-0.143-277%-0.038-0.0380%-0.288+660%-0.598+1478%-0.478+1162%
Price Per Share0.532+73%0.1410.1410%1.000-86%1.122-87%0.885-84%
Price To Free Cash Flow Ratio-0.253-277%-0.067-0.0670%-0.427+536%-0.701+944%-0.561+736%
Price To Total Gains Ratio-0.158-277%-0.042-0.0420%0.368-111%3.970-101%2.169-102%
Quick Ratio--0.7510.7510%1.870-60%1.365-45%1.080-30%
Return On Assets---1.422-1.4220%-0.486-66%-0.994-30%-1.603+13%
Return On Equity---4.850-4.8500%-0.844-83%-2.696-44%-3.283-32%
Total Gains Per Share---3.360-3.3600%2.716-224%0.266-1361%0.147-2382%
Usd Book Value--7575945.0007575945.0000%41217080.000-82%15517272.000-51%7974881.800-5%
Usd Book Value Change Per Share---3.360-3.3600%2.000-268%0.123-2824%0.076-4541%
Usd Book Value Per Share--0.7570.7570%4.116-82%1.550-51%0.796-5%
Usd Dividend Per Share----0%0.716-100%0.143-100%0.072-100%
Usd Eps---3.723-3.7230%-3.476-7%-2.479-33%-1.928-48%
Usd Free Cash Flow---21040470.000-21040470.0000%-23462891.000+12%-18157855.200-14%-15023032.900-29%
Usd Free Cash Flow Per Share---2.101-2.1010%-2.343+12%-1.813-14%-1.500-29%
Usd Free Cash Flow To Equity Per Share---2.774-2.7740%2.396-216%0.200-1485%0.034-8216%
Usd Market Cap5327182.000+73%1411903.5001411903.5000%10013500.000-86%11237149.700-87%8859744.530-84%
Usd Price Per Share0.532+73%0.1410.1410%1.000-86%1.122-87%0.885-84%
Usd Profit---36742544.000-36742544.0000%-34805712.000-5%-24422197.400-34%-18982894.500-48%
Usd Revenue--2607293.0002607293.0000%4306031.000-39%3514537.200-26%3450408.300-24%
Usd Total Gains Per Share---3.360-3.3600%2.716-224%0.266-1361%0.147-2382%
 EOD+5 -3MRQTTM+0 -0YOY+6 -305Y+3 -3310Y+4 -32

4.2. Fundamental Score

Let's check the fundamental score of OpGen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.143
Price to Book Ratio (EOD)Between0-10.703
Net Profit Margin (MRQ)Greater than0-14.092
Operating Margin (MRQ)Greater than0-13.258
Quick Ratio (MRQ)Greater than10.751
Current Ratio (MRQ)Greater than11.006
Debt to Asset Ratio (MRQ)Less than10.707
Debt to Equity Ratio (MRQ)Less than12.410
Return on Equity (MRQ)Greater than0.15-4.850
Return on Assets (MRQ)Greater than0.05-1.422
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of OpGen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.134
Ma 20Greater thanMa 500.649
Ma 50Greater thanMa 1000.563
Ma 100Greater thanMa 2000.473
OpenGreater thanClose0.555
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Gross Profit  1,0987691,867-1,5013661,0921,458-2,274-817



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets25,831
Total Liabilities18,255
Total Stockholder Equity7,576
 As reported
Total Liabilities 18,255
Total Stockholder Equity+ 7,576
Total Assets = 25,831

Assets

Total Assets25,831
Total Current Assets10,655
Long-term Assets15,175
Total Current Assets
Cash And Cash Equivalents 7,440
Net Receivables 514
Inventory 1,345
Other Current Assets 1,356
Total Current Assets  (as reported)10,655
Total Current Assets  (calculated)10,655
+/-0
Long-term Assets
Property Plant Equipment 4,938
Intangible Assets 7,441
Other Assets 2,796
Long-term Assets  (as reported)15,175
Long-term Assets  (calculated)15,175
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,590
Long-term Liabilities7,664
Total Stockholder Equity7,576
Total Current Liabilities
Short-term Debt 7,404
Short Long Term Debt 7,024
Accounts payable 421
Other Current Liabilities 2,624
Total Current Liabilities  (as reported)10,590
Total Current Liabilities  (calculated)17,472
+/- 6,882
Long-term Liabilities
Long term Debt 4,851
Capital Lease Obligations 2,947
Other Liabilities 229
Long-term Liabilities Other 129
Long-term Liabilities  (as reported)7,664
Long-term Liabilities  (calculated)8,156
+/- 492
Total Stockholder Equity
Common Stock29
Retained Earnings -272,824
Accumulated Other Comprehensive Income -796
Other Stockholders Equity 281,167
Total Stockholder Equity (as reported)7,576
Total Stockholder Equity (calculated)7,576
+/-0
Other
Capital Stock29
Cash and Short Term Investments 7,440
Common Stock Shares Outstanding 2,442
Current Deferred Revenue142
Liabilities and Stockholders Equity 25,831
Net Debt 7,399
Net Invested Capital 19,450
Net Tangible Assets 135
Net Working Capital 64
Property Plant and Equipment Gross 4,938
Short Long Term Debt Total 14,839



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
3,159
2,655
13,763
8,984
6,620
8,950
10,422
49,751
71,667
25,831
25,83171,66749,75110,4228,9506,6208,98413,7632,6553,159
   > Total Current Assets 
1,964
1,713
9,891
5,682
3,502
5,783
6,667
16,888
39,743
10,655
10,65539,74316,8886,6675,7833,5025,6829,8911,7131,964
       Cash And Cash Equivalents 
1,400
750
7,814
4,117
1,847
4,572
2,708
13,360
36,080
7,440
7,44036,08013,3602,7084,5721,8474,1177,8147501,400
       Net Receivables 
242
504
679
542
810
374
3,089
653
1,172
514
5141,1726533,089374810542679504242
       Inventory 
176
370
826
692
533
544
473
1,486
1,239
1,345
1,3451,2391,486473544533692826370176
       Other Current Assets 
146
90
572
330
312
293
397
1,388
1,250
1,356
1,3561,2501,38839729331233057290146
   > Long-term Assets 
1,194
941
3,871
3,302
3,118
3,167
3,755
32,863
31,924
15,175
15,17531,92432,8633,7553,1673,1183,3023,8719411,194
       Property Plant Equipment 
1,079
588
1,075
801
836
1,222
2,133
5,791
5,917
4,938
4,9385,9175,7912,1331,2228368011,0755881,079
       Goodwill 
0
0
638
601
601
601
601
8,025
7,453
0
07,4538,02560160160160163800
       Intangible Assets 
58
0
1,889
1,621
1,353
1,085
818
16,581
14,530
7,441
7,44114,53016,5818181,0851,3531,6211,889058
       Long-term Assets Other 
57
354
270
280
329
259
203
2,466
4,024
2,796
2,7964,0242,46620325932928027035457
> Total Liabilities 
4,990
10,721
6,272
5,817
5,219
5,642
6,128
28,560
30,449
18,255
18,25530,44928,5606,1285,6425,2195,8176,27210,7214,990
   > Total Current Liabilities 
2,756
6,022
4,894
5,272
4,790
4,381
4,939
7,372
19,917
10,590
10,59019,9177,3724,9394,3814,7905,2724,8946,0222,756
       Short-term Debt 
116
3,105
252
1,208
1,166
798
1,970
1,930
15,022
7,404
7,40415,0221,9301,9707981,1661,2082523,105116
       Short Long Term Debt 
0
5
1,574
1,024
1,011
399
374
699
14,519
7,024
7,02414,5196993743991,0111,0241,57450
       Accounts payable 
869
1,160
2,286
2,233
1,692
1,624
1,056
1,869
1,307
421
4211,3071,8691,0561,6241,6922,2332,2861,160869
       Other Current Liabilities 
1,261
1,417
2,305
1,794
1,908
1,944
1,903
3,564
3,588
2,624
2,6243,5883,5641,9031,9441,9081,7942,3051,4171,261
   > Long-term Liabilities 
2,234
4,699
1,378
545
429
1,261
1,190
21,188
10,533
7,664
7,66410,53321,1881,1901,2614295451,3784,6992,234
       Long term Debt Total 
0
0
1,322
147
130
660
329
19,379
0
0
0019,3793296601301471,32200
       Long term Debt 
234
134
994
0
130
660
329
19,379
7,176
4,851
4,8517,17619,3793296601300994134234
       Capital Lease Obligations 
0
0
0
331
285
837
2,457
2,770
3,484
2,947
2,9473,4842,7702,457837285331000
       Other Liabilities 
0
0
353
398
299
163
0
269
375
229
229375269016329939835300
       Long-term Liabilities Other 
0
0
0
147
139
437
860
157
147
129
129147157860437139147000
       Deferred Long Term Liability 
0
296
0
398
291
163
0
113
0
0
00113016329139802960
> Total Stockholder Equity
-1,831
-8,066
7,491
3,167
1,401
3,309
4,293
21,191
41,217
7,576
7,57641,21721,1914,2933,3091,4013,1677,491-8,066-1,831
   Common Stock
4
5
125
253
23
86
56
251
465
29
2946525156862325312554
   Retained Earnings -272,824-235,542-200,736-174,525-162,079-148,684-133,291-114,124-96,772-91,101
   Accumulated Other Comprehensive Income 
-3,396
-3,823
-1
6
-52
-13
-17
2,547
586
-796
-7965862,547-17-13-526-1-3,823-3,396
   Capital Surplus 
0
0
121,491
136,199
150,115
165,314
178,780
219,129
0
0
00219,129178,780165,314150,115136,199121,49100
   Treasury Stock0000000000
   Other Stockholders Equity 
92,662
92,525
127,074
142,014
156,298
165,314
178,780
219,129
275,708
281,167
281,167275,708219,129178,780165,314156,298142,014127,07492,52592,662



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,070
Cost of Revenue-2,867
Gross Profit203203
 
Operating Income (+$)
Gross Profit203
Operating Expense-21,425
Operating Income-18,355-21,222
 
Operating Expense (+$)
Research Development5,956
Selling General Administrative12,603
Selling And Marketing Expenses-
Operating Expense21,42518,558
 
Net Interest Income (+$)
Interest Income105
Interest Expense-2,336
Other Finance Cost-0
Net Interest Income-2,231
 
Pretax Income (+$)
Operating Income-18,355
Net Interest Income-2,231
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-26,162-12,780
EBIT - interestExpense = -2,336
-26,162
-23,826
Interest Expense2,336
Earnings Before Interest and Taxes (EBIT)--23,826
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-26,162
Tax Provision-0
Net Income From Continuing Ops-26,162-26,162
Net Income-26,162
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-5,5762,231
 

Technical Analysis of Opgen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Opgen. The general trend of Opgen is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Opgen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of OpGen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.84 < 0.99 < 2.08.

The bearish price targets are: 0.4879 > 0.455 > 0.451.

Tweet this
OpGen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of OpGen Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

OpGen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of OpGen Inc. The current macd is 0.00209331.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Opgen price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Opgen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Opgen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
OpGen Inc Daily Moving Average Convergence/Divergence (MACD) ChartOpGen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of OpGen Inc. The current adx is 28.07.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Opgen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
OpGen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of OpGen Inc. The current sar is 0.89716878.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
OpGen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of OpGen Inc. The current rsi is 41.13. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
OpGen Inc Daily Relative Strength Index (RSI) ChartOpGen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of OpGen Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Opgen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
OpGen Inc Daily Stochastic Oscillator ChartOpGen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of OpGen Inc. The current cci is -143.52589493.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
OpGen Inc Daily Commodity Channel Index (CCI) ChartOpGen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of OpGen Inc. The current cmo is -33.1208109.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
OpGen Inc Daily Chande Momentum Oscillator (CMO) ChartOpGen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of OpGen Inc. The current willr is -97.40670462.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
OpGen Inc Daily Williams %R ChartOpGen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of OpGen Inc.

OpGen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of OpGen Inc. The current atr is 0.06806369.

OpGen Inc Daily Average True Range (ATR) ChartOpGen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of OpGen Inc. The current obv is 257,069,467.

OpGen Inc Daily On-Balance Volume (OBV) ChartOpGen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of OpGen Inc. The current mfi is 54.96.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
OpGen Inc Daily Money Flow Index (MFI) ChartOpGen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for OpGen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

OpGen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of OpGen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.134
Ma 20Greater thanMa 500.649
Ma 50Greater thanMa 1000.563
Ma 100Greater thanMa 2000.473
OpenGreater thanClose0.555
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Opgen with someone you think should read this too:
  • Are you bullish or bearish on Opgen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Opgen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about OpGen Inc

I send you an email if I find something interesting about OpGen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about OpGen Inc.

Receive notifications about OpGen Inc in your mailbox!